NCT/Study#
NA /
DGF60021-600201
Dose Escalation In Patients With Advanced Solid Tumors, And Expansion In Selected Indications
DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
NA
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
